Skip to main content

Nonprofit · EIN 02-0715210

FIBROUS DYSPLASIA FOUNDATION INC

Tax-exempt · BETHESDA, MD 20814

Financials

$323K$388K2023$246K$270K2024
Revenue Expenses · by fiscal year end
Financials of FIBROUS DYSPLASIA FOUNDATION INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
June 30, 2025990$245,764$270,098-$24,334$243,546$237,726$5,820
June 30, 2024990$322,942$388,138-$65,196$267,364$237,210$30,154
Financial details: 990 for the year ended June 30, 2025

Revenue

Contributions, gifts and grants
$238,806
Program service revenue
$0
Investment income
$6,958
Other revenue
$0

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$107,492
Other salaries and wages
$79,240
Salaries, compensation and benefits (total)
$200,293
Professional fundraising fees
$0
Accounting fees
$5,750
Travel
$5,118
Program services (functional)
$200,715
Management and general (functional)
$47,976
Fundraising (functional)
$21,407

Balance sheet and other

Total assets, start of year
$267,364
Total assets, end of year
$243,546
Total liabilities, end of year
$237,726
Net assets, end of year
$5,820
Net assets without donor restrictions
$5,820
Gross receipts
$245,764
Employees
3
Volunteers
100
Year formed
2004
State of legal domicile
FL

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended June 30, 2025, highest compensation first.

NameTitleHours / weekCompensation
ADRIENNE MCBRIDEEXECUTIVE DI
Officer
40$88,857
ANNE CORVELLEBOARD PRESID
Trustee or director, Officer
2$0
CINDI BRANDT LEVINBOARD VICE P
Trustee or director, Officer
2$0
CHRISTOPHER GUESTTREASURER
Trustee or director, Officer
2$0
MALISSA KENNEYSECRETARY
Trustee or director, Officer
2$0
MICHAEL COLLINSDIRECTOR
Trustee or director
0.5$0
JUSTIN COHENDIRECTOR
Trustee or director
0.5$0
JUSTIN HEALYDIRECTOR
Trustee or director
0.5$0
ERIC CHIEN-WEI LIAODIRECTOR
Trustee or director
0.5$0
GARY POLLASTRODIRECTOR
Trustee or director
0.5$0
CARMEL SHEMMESH-RAFALOWSKYDIRECTOR
Trustee or director
0.5$0
990 for the year ended June 30, 2024: 12 people
NameTitleHours / weekCompensation
ADRIENNE MCBRIDEEXECUTIVE DI
Officer
40$82,142
ANNE CORVELLEBOARD PRESID
Trustee or director, Officer
2$0
CINDI BRANDT LEVINBOARD VICE P
Trustee or director, Officer
2$0
CHRIS GUESTTREASURER
Trustee or director, Officer
2$0
MALISSA KENNEYSECRETARY
Trustee or director, Officer
2$0
NICOLA DEELEYDIRECTOR
Trustee or director
0.5$0
JUSTIN COHENDIRECTOR
Trustee or director
0.5$0
JUSTIN HEALYDIRECTOR
Trustee or director
0.5$0
ERIC CHIEN-WEI LIAODIRECTOR
Trustee or director
0.5$0
GARY POLLASTRODIRECTOR
Trustee or director
0.5$0
CARMEL SHEMMESH-RAFALOWSKYDIRECTOR
Trustee or director
0.5$0
LAUREN RUOTOLODIRECTOR
Trustee or director
0.5$0

Address and contacts

Address (IRS master file)
7315 WISCONSIN AVE, BETHESDA, MD 20814-3202
In care of
% LAUREN RUOTOLO PRESIDENT
Principal officer (990 for 2024)
ANNE CORVELLE, 848 LANDIS AVE, LANCASTER, PA 17603
Signed the 990
ANNE CORVELLE, BOARD PRESIDENT
Phone
(301) 467-8979
Return prepared by
TAYLOR ROTH AND COMPANY

Mission

THE FIBROUS DYSPLASIA FOUNDATION SERVES PEOPLE AFFECTED WITH FIBROUS DYSPLASIA/MCCUNE-ALBRIGHT SYNDROME THROUGH PROGRAMS OF RESEARCH, EDUCATION, AWARENESS AND SUPPORT.

990 for the year ended June 30, 2025

Program accomplishments

  • RESEARCH PROGRAMS: -IN 2025, TEAM FD/MAS AWARDED TWO RESEARCH GRANTS TOTALING OVER 120,000 TO ADVANCE FD/MAS SPECIFIC RESEARCH: --DR. ARIANE ZAMARIOLI OF RIBEIRAO PRETO MEDICAL SCHOOL RECEIVED 40,234.00 FOR HER PROJECT ELUCIDATING A LINK BETWEEN MICROFRACTURES AND FIBROUS DYSPLASIA BONE PAIN IN MICE. --DR. J. SILVIO GUTKIND OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO, RECEIVED 80,468.00 FOR HIS PROJECT TARGETING GNAS-DRIVEN PATHWAY FOR PRECISION THERAPY OF FIBROUS DYSPLASIA. -HOSTED TWO RESEARCH UPDATES --DR. MARC WEIN OF MASS GENERAL HOSPITAL SHARED FINDINGS FROM HIS PRMRP- FUNDED PROJECT, FOCUSING ON THERAPEUTIC CONCEPTS THAT HAVE EMERGED FROM HIS BASIC SCIENCE STUDIES. --IN JUNE, ALISON BOYCE SHARED RESEARCH UPDATES FROM HER PHASE TWO CLINICAL TRIAL OF BUROSUMAB, WHICH HELPS REGULATE PHOSPHATE LEVELS -SUPPORT AND MAINTENANCE OF THE FD/MAS PATIENT REGISTRY, AN IRB-APPROVED STUDY.
    Expenses $74,265
  • ADVOCACY PROGRAMS: -ALLIANCE ADVOCATES SECURED ANOTHER YEAR OF ACCESS TO THE PEER-REVIEWED MEDICAL RESEARCH PROGRAM (PRMRP) AND 150 MILLION OF POSSIBLE RESEARCH FUNDS -ADRIENNE MCBRIDE SAT ON THE GLOBAL GENES CORPORATE ALLIANCE COMMITTEE THAT DEVELOPED A NEW WHITE PAPER, "EARLY AND OFTEN: REIMAGINING PATIENT COMMUNITY ENGAGEMENT TO IMPROVE CLINICAL TRIALS FEASIBILITY," WHICH SHOWS THE TRANSFORMATIVE ROLE OF PATIENT ADVOCACY ORGANIZATIONS IN RARE DISEASE DRUG DEVELOPMENT. -FACES OF FD/MAS IS AN FD/MAS ALLIANCE VIDEO PROJECT ENVISIONED AND GUIDED BY THE PATIENT ADVISORY COUNCIL (PAC). THE PROJECT AIMS TO CAPTURE THE DIVERSE EXPERIENCES OF THOSE IN THE FIBROUS DYSPLASIA, MCCUNE-ALBRIGHT SYNDROME (FD/MAS) COMMUNITY. VIDEOS WERE RELEASED THROUGHOUT 2024 AND 2025.
    Expenses $56,200
  • EDUCATION PROGRAM: -WE EMPOWER THE FD/MAS COMMUNITY WITH THE BEST EDUCATIONAL RESOURCES AND SHARE THESE RESOURCES ON THE FD/MAS ALLIANCE'S WEBSITE AND YOUTUBE CHANNEL. WE PRODUCE AND SHARE EDUCATIONAL WEBINARS FOR PATIENTS AND CAREGIVERS." -MONTHLY WEB PROGRAMMING, DESIGNED AND HOSTED BY FD/MAS ALLIANCES PATIENT ADVISORY COUNCIL, OFFERS AN OPPORTUNITY FOR PATIENTS AND CAREGIVERS TO CONNECT, SHARE EXPERIENCES, AND ASK QUESTIONS IN A SAFE AND SUPPORTIVE SPACE. THIS YEAR, PROGRAMS COVERED TOPICS FOCUSED ON QUALITY OF LIFE AS WELL AS MEDICAL AND EDUCATIONAL PROGRAMMING: LIVING INDEPENDENTLY WITH FD/MAS NAVIGATING RELATIONSHIPS WITH FD/MAS ENCOURAGING SELF-ADVOCACY TOOLS FOR TOUGH TIMES CLINICAL TRIALS 101 PSYCHOLOGY IN PEDIATRIC CARE
    Expenses $54,193
  • FD/MAS ALLIANCE, IN ADDITION TO ITS OTHER PROGRAM SERVICES: - MAINTAINS A COMPREHENSIVE, UP-TO-DATE REPOSITORY OF INFORMATION FOR PATIENTS, CAREGIVERS, AND MEDICAL PRACTITIONERS, INCLUDING RECENT RESEARCH PUBLICATIONS, DIAGNOSIS AND TREATMENT GUIDELINES, RELEVANT FUNDING OPPORTUNITIES FOR BASIC AND CLINICAL INVESTIGATORS, AND INFORMATION ON ONGOING CLINICAL TRIALS IN FD/MAS. - EXPANDS AND STRENGTHENS THE NETWORK OF FD/MAS RESEARCHERS AND PATIENT ADVOCATES WORLDWIDE THROUGH EDUCATION, COMMUNICATIONS, AND ALLIANCE- BUILDING INITIATIVES, INCLUDING A BIENNIAL CONFERENCE. - REMOTELY ATTENDS OR, WHEN SUITABLE, TRAVELS TO BOTH DOMESTIC AND INTERNATIONAL SCIENTIFIC GATHERINGS TO ADVOCATE FOR FD/MAS RESEARCH OPPORTUNITIES TO BROADEN THE NETWORK OF INVOLVED RESEARCHERS AND OTHER STAKEHOLDERS WORKING ON POTENTIAL THERAPIES. - PROVIDES MENTORING AND COMMUNITY BUILDING AMONG OTHER FD/MAS PATIENT ORGANIZATIONS TO ENHANCE THE EFFECTIVENESS AND COORDINATION OF THESE GROUPS WORLDWIDE.
    Expenses $16,057

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025June 30, 2026November 16, 2026Not due yet
2024June 30, 2025November 17, 2025990 on file
2023June 30, 2024November 15, 2024990 on file

IRS record

EIN
02-0715210
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2005
Accounting year ends
June
Files
Form 990 or 990-EZ
Assets (IRS master file)
$243,546
Income (IRS master file)
$245,764

Filing history

FormYear endedRevenueExpensesAssetsReturn
990June 2025$245,764$270,098$243,546XML
990June 2024$322,942$388,138$267,364XML
990June 2023$282,768$377,909$329,399IRS
990June 2022–––IRS
990June 2021–––IRS
990June 2020–––IRS
990June 2019–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 02-0715210).

Questions about FIBROUS DYSPLASIA FOUNDATION INC

What is the EIN of FIBROUS DYSPLASIA FOUNDATION INC?
The employer identification number (EIN) of FIBROUS DYSPLASIA FOUNDATION INC is 02-0715210.
Is FIBROUS DYSPLASIA FOUNDATION INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2005.
Are donations to FIBROUS DYSPLASIA FOUNDATION INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does FIBROUS DYSPLASIA FOUNDATION INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of FIBROUS DYSPLASIA FOUNDATION INC due?
The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did FIBROUS DYSPLASIA FOUNDATION INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended June 2025.
Who is the principal officer of FIBROUS DYSPLASIA FOUNDATION INC?
The 990 for the year ended June 30, 2025 names ANNE CORVELLE.
Who are the officers and directors of FIBROUS DYSPLASIA FOUNDATION INC?
The 990 for the year ended June 30, 2025 lists 11 people; 1 received compensation from the organization, the highest $88,857 (ADRIENNE MCBRIDE, EXECUTIVE DI).
How much revenue does FIBROUS DYSPLASIA FOUNDATION INC have?
On its 990 for the year ended June 30, 2025 it reported revenue of $245,764, expenses of $270,098 and total assets of $243,546 at year end.

Other nonprofits in BETHESDA

All nonprofits in BETHESDA · Maryland · Voluntary health associations and medical disciplines